Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa
Epidermolysis bullosa is a group of genetic skin conditions characterized by abnormal skin (and mucosal) fragility caused by pathogenic variants in various genes. The disease severity ranges from early childhood mortality in the most severe types to occasional acral blistering in the mildest types....
Guardado en:
Autores principales: | Franciscus C. Vermeer, Jeroen Bremer, Robert J. Sietsma, Aileen Sandilands, Robyn P. Hickerson, Marieke C. Bolling, Anna M.G. Pasmooij, Henny H. Lemmink, Morris A. Swertz, Nine V.A.M. Knoers, K. Joeri van der Velde, Peter C. van den Akker |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1311e30c58c5407bb9cef31de25b8743 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Digenic Mutations in Junctional Epidermolysis Bullosa in An Iranian Family
por: Kourosh Riahi, et al.
Publicado: (2021) -
Kidney and Urinary Tract Involvement in Epidermolysis Bullosa: Is Routine Follow-Up Necessary?
por: Neslihan Cicek, et al.
Publicado: (2021) -
Mitrofanoff continent vesicostomy as a treatment option for epidermolysis bullosa complicated by posterior urethral stenosis
por: A. Kissel, et al.
Publicado: (2022) -
Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex
por: Nadezhda A. Evtushenko, et al.
Publicado: (2021) -
Impact of low-dose calcipotriol ointment on wound healing, pruritus and pain in patients with dystrophic epidermolysis bullosa: A randomized, double-blind, placebo-controlled trial
por: Christina Guttmann-Gruber, et al.
Publicado: (2021)